Abstract

TO STUDY DRUG PRESCRIBING PATTERN, COST AND CLINICAL BENEFITS IN MYOCARDIAL INFARCTION PATIENTS IN TERTIARY CARE HOSPITAL – A PROSPECTIVE OBSERVATIONAL STUDY

Dr. Anil Joshi*, Priyanka Singh, Poorva Kanade, Nisharg Patel and Dr. Sadhana Shahi

ABSTRACT

Objective: To study drug prescribing pattern, cost and clinical benefits in Myocardial Infarction patients in tertiary care hospital- A Prospective Observational Study. Method: 262 samples were included in the study, detailed history was taken and noted in the designed proforma. Drugs prescribed and cost of therapy was analyzed. On follow-up, patients were enquired for clinical benefits, improvement or deterioration in clinical conditions. Result: Out of 262 patients maximum were males 182 (69.47%). Prevalence of Myocardial Infarction was found to be higher among age group 51-60 years (32.82%) while least number of patients were observed in age group of below 20 years and above 80 years. Categories of drugs for management of Myocardial Infarction were Antihyperlipidemic 252 (96.18%), 249 (95.04%) Antiplatelet, 176 (67.18%) Antihypertensives, 139 (53.05%) Thrombolytics, 128 (48.85%) Antianginal, 122 (46.56%) Anticoagulant, respectively. Certain untoward reactions revealed the frequency of headache, muscle weakness, and syncope. The occurrence of haematemesis and haematuria was less. The study revealed the minimum and maximum cost per day hospitalization borne by the patient was from Rs.0 to Rs. 35.83. Average cost for the management of MI is Rs. 24.45 per day excluding the cost of Anticoagulant and Thrombolytic drugs which was borne by Government hospital. Conclusion: The prevalence of MI is more in males as compared to females. The cost of medicines purchased by patients varied from Rs. 0 to Rs. 35 with an average cost of Rs. 24 because all other cost were borne by Government hospital.

Keywords: Myocardial Infarction, Prescribing Pattern, Clinical benefits.